H M Lazarus

5.2k total citations · 1 hit paper
66 papers, 3.8k citations indexed

About

H M Lazarus is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, H M Lazarus has authored 66 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 27 papers in Oncology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in H M Lazarus's work include Hematopoietic Stem Cell Transplantation (33 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (12 papers). H M Lazarus is often cited by papers focused on Hematopoietic Stem Cell Transplantation (33 papers), Acute Myeloid Leukemia Research (13 papers) and Acute Lymphoblastic Leukemia research (12 papers). H M Lazarus collaborates with scholars based in United States, United Kingdom and Canada. H M Lazarus's co-authors include S L Gerson, William Krivit, John Day, Michael L. Nieder, BW Cooper, MJ Kennedy, NE Davidson, MS Tallman, Steven M. Devine and Jeffery J. Auletta and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

H M Lazarus

66 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)

2002 508 citations John Day, Michael L. Nieder et al. Bone Marrow Transplantation profile →

Peers

Countries citing papers authored by H M Lazarus

Since Specialization

Citations

This map shows the geographic impact of H M Lazarus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H M Lazarus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H M Lazarus more than expected).

Fields of papers citing papers by H M Lazarus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H M Lazarus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H M Lazarus. The network helps show where H M Lazarus may publish in the future.

Co-authorship network of co-authors of H M Lazarus

This figure shows the co-authorship network connecting the top 25 collaborators of H M Lazarus. A scholar is included among the top collaborators of H M Lazarus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H M Lazarus. H M Lazarus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults 2017 ·Bone Marrow Transplantation ·Mark R. Litzow, Adele K. Fielding, Selina M. Luger, Elisabeth Paietta, Yishai Ofran, Jacob M. Rowe, Anthony H. Goldstone, Martin S. Tallman, H M Lazarus	13
2	Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapy 2017 ·Bone Marrow Transplantation ·Boglarka Gyurkocza, H M Lazarus, Sergio Giralt	33
3	Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? 2007 ·Bone Marrow Transplantation ·Amanda F. Cashen, H M Lazarus, Steven M. Devine	90
4	Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation 2007 ·Contemporary Clinical Trials ·Ping Fu, Willem J. van Heeckeren, Punit D. Wadhwa, David J. Bajor, Richard J. Creger, Xu Zhou, Brenda Cooper, Mary J. Laughlin, Stanton L. Gerson, (unknown), H M Lazarus	4
5	Immune restoration following hematopoietic stem cell transplantation: an evolving target 2005 ·Bone Marrow Transplantation ·Jeffery J. Auletta, H M Lazarus	82
6	Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients 2004 ·Bone Marrow Transplantation ·(unknown), Mahmoud A. Ghannoum, H M Lazarus	32
7	Adult patients with acute lymphoblastic leukaemia (ALL) who relapse have a dismal outlook: Results from MRC UKALL XII/ECOG 2993 trial. 2003 ·Blood ·Reena Chopra, A H Goldstone, Georgina Buck, S Richards, Ian M. Franklin, H M Lazarus, (unknown), Martin S. Tallman, H. G. Prentice, Jill Durrant, Jacob M. Rowe	1
8	Randomized, Multicenter, Open-Label Study of Pegfilgrastim Compared With Daily Filgrastim After Chemotherapy for Lymphoma 2003 ·Journal of Clinical Oncology ·Julie Vose, Michael Crump, H M Lazarus, (unknown), David P. Schenkein, Joseph O. Moore, (unknown), Ian W. Flinn, Wade Lovelace, James Hackett, Bertrand C. Liang	152
9	Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) breakdown → 2002 ·Bone Marrow Transplantation ·(unknown), John Day, Michael L. Nieder, S L Gerson, H M Lazarus, William Krivit	508
10	Allogeneic transplant (related or unrelated donor) is the preferred treatment for adult Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL). Results from the international ALL trial (MRC UKALLXII/ECOG E2993) 2001 ·Blood ·A H Goldstone, H. G. Prentice, Jill Durrant, I M Franklin, G Harrison, Stephanie Richards, H M Lazarus, P H Wiernik, Martin S. Tallman, (unknown)	21
11	Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993). 2001 ·Blood ·Jacob M. Rowe, Stephanie Richards, Alan K. Burnett, P H Wiernik, G Harrison, H M Lazarus, I M Franklin, G Prentice, Jill Durrant, Martin S. Tallman, A. H. Goldstone	21
12	Erythropoietin in stem cell transplantation 2001 ·Bone Marrow Transplantation ·(unknown), H M Lazarus	9
13	Chronic graft-versus-host disease: clinical manifestation and therapy 2001 ·Bone Marrow Transplantation ·Voravit Ratanatharathorn, Lois Ayash, H M Lazarus, Jianing Fu, (unknown)	183
14	Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer 2001 ·Cytotherapy ·Robert A. Preti, H M Lazarus, Jane N. Winter, Edward A. Stadtmauer, (unknown), J. McMannis, Safa Karandish, (unknown), Stuart L. Goldberg, Andrew L. Pecora	11
15	Autologous CD34+ enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation 2000 ·Bone Marrow Transplantation ·(unknown), H M Lazarus, (unknown)	23
16	Philadelphia chromosome plus ve patients with adult acute lymphoblastic leukaemia (ALL), early results from the international ALL trial (MRC UKALL-XII/ECOG E2993). 1999 ·Blood ·A H Goldstone, Stephanie Richards, P H Wiernik, I M Franklin, Alan K. Burnett, H M Lazarus, H. G. Prentice, Donna Neuberg, Martin S. Tallman, G Harrison, Jacob M. Rowe	1
17	Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients ( > 55 to 70 years of age) with acute myelogenous leukemia 1999 ·Annals of Oncology ·Charles L. Bennett, (unknown), Martin S. Tallman, Edward A. Stadtmauer, Robert Marsh, William R. Friedenberg, H M Lazarus, Lynne Kaminer, Robert Golub, Jacob M. Rowe	46
18	Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation 1998 ·Bone Marrow Transplantation ·(unknown), Roslyn Yomtovían, H M Lazarus, Nancy S. Rosenthal	28
19	Comparative Analysis of Breast Cancer Contamination in Mobilized and Nonmobilized Hematopoietic Grafts 1996 ·Journal of Hematotherapy ·(unknown), (unknown), (unknown), José Luís Passos‐Coelho, John M. Davis, A M Huelskamp, Stephen J. Noga, Nancy E. Davidson, Esther M. John, Brenda Cooper, S L Gerson, H M Lazarus, Kent Holland, Stefan Glück, TJ Moss, (unknown), Linda T. Vahdat, Karen H. Antman	11
20	A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets 1993 ·Transfusion ·Roslyn Yomtovían, H M Lazarus, Lawrence T. Goodnough, Nora V. Hirschler, (unknown), Michael R. Jacobs	176

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact